Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.
Prosz A, Duan H, Tisza V, Sahgal P, Topka S, Klus GT, Börcsök J, Sztupinszki Z, Hanlon T, Diossy M, Vizkeleti L, Stormoen DR, Csabai I, Pappot H, Vijai J, Offit K, Ried T, Sethi N, Mouw KW, Spisak S, Pathania S, Szallasi Z.
Prosz A, et al. Among authors: mouw kw.
Sci Rep. 2023 Nov 23;13(1):20567. doi: 10.1038/s41598-023-47946-4.
Sci Rep. 2023.
PMID: 37996508
Free PMC article.